Blocking Pannexin 1 Channels Alleviates Peripheral Inflammatory Pain but not Paclitaxel-Induced Neuropathy

Area of Science:

• Neuroscience
• Molecular Biology
• Pain Research

Background:

• Pannexin1 (Panx1) is a channel protein implicated in pain and inflammation.
• Its role in central nervous system pain is known, but its function in peripheral neuronal sensitization remains unclear.
• The dorsal root ganglion (DRG) is crucial for pain processing, making its molecular mechanisms a target for pain treatment.

Purpose of the Study:

• To investigate the role of Panx1 in acute nociception and peripheral inflammatory and neuropathic pain.
• To explore Panx1's involvement in DRG neuronal sensitization.
• To assess Panx1's contribution to pain development using pharmacological blockade and genetic knockout models.

Main Methods:

• Rats received Panx1 blocker (10Panx) in L5-DRG, followed by inflammatory stimuli (carrageenan, formalin, capsaicin).
• DRG neurons were pre-treated with 10Panx and stimulated with capsaicin to measure calcium influx.
• Panx1 knockout (Panx1-KO) mice and wildtype (WT) mice were treated with carrageenan, capsaicin, or paclitaxel, with mechanical thresholds assessed via von Frey test.

Main Results:

• Panx1 blockade in rat DRG dose-dependently reduced carrageenan-induced allodynia and formalin-induced nociception.
• Capsaicin-induced pain and calcium influx were significantly lower in Panx1-blocked rats and Panx1-KO mice.
• Paclitaxel induced acute pain in WT but not Panx1-KO mice; chronic pain developed in both, but was less severe in Panx1-KO mice initially.

Conclusions:

• Panx1 is critical for peripheral inflammatory pain and acute nociception involving TRPV1.
• Panx1 is not essential for the chronicity of neuropathic pain.
• Targeting Panx1 in the DRG may offer therapeutic potential for inflammatory and acute pain conditions.